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Abstract  
 
Cannabis exerts its psychoactive effect through cannabinoid receptors that are widely 
distributed across the cortical surface of the human brain. It is suggested that cannabis 
use may contribute to structural alterations across the cortical surface. In a large, 
multisite dataset of 120 controls and 141 cannabis users, we examined whether 
differences in key characteristics of the cortical surface – including cortical thickness, 
surface area, and gyrification index were related to cannabis use characteristics, 
including (i) cannabis use vs. non-use, (ii) cannabis dependence vs. non-dependence 
vs. non-use, and (iii) early adolescent vs. late adolescent onset of cannabis use vs. 
non-use. Our results revealed that cortical morphology was not associated with 
cannabis use, dependence, or onset age. The lack of effect of regular cannabis use, 
including problematic use, on cortical structure in our study is contrary to previous 
evidence of cortical morphological alterations (particularly in relation to cannabis 
dependence and cannabis onset age) in cannabis users. Careful reevaluation of the 
evidence on cannabis-related harm will be necessary to address concerns surrounding 
the long-term effects of cannabis use and inform policies in a changing cannabis 
regulation climate.  
 
Keywords = cannabis; cortical surface; MRI; dependence; substance use 
 
Word count = 3078 words 
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1. Introduction 
 
Cannabis is a widely used recreational substance, valued for both its pharmacological 
and psychoactive properties (Atakan, 2012). While cannabis remains illegal in most 
countries, a number of countries have begun to decriminalise or permit its use for 
personal or medical purposes. This general shift in attitude has raised concerns about 
the potential harm of long-term cannabis use, particularly for users who begun using 
at an early age (Hall and Lynskey, 2016; Levine et al., 2016). The majority of 
cannabis initiates are adolescents under the age of 18 (Center for Behavioral Health 
Statistics and Quality, 2011). Early adolescent initiates may be at a greater risk of 
worse functional outcomes including, poorer academic performance and delinquency 
(Brook et al., 1999; Fergusson and Horwood, 1997; Lynskey et al., 2015; Meier et al., 
2015). Additionally, initiation of use during adolescence is associated with a greater 
likelihood of persistent use and dependence later in life (Center for Behavioral Health 
Statistics and Quality, 2011; DeWit et al., 1997; Perkonigg et al., 2008). Not only do 
dependent cannabis users experience a range of physiological and psychological 
problems (e.g., social, interpersonal, and mental health issues including mood, anxiety 
and behavioral disorders) related to use (American Psychiatric Association, 2013; 
Hasin et al., 2013; van der Pol et al., 2013), cannabis dependence may also be 
associated with distinct brain alterations relative to non-dependent use (Chye et al., 
2017b, 2017c; Filbey and Dunlop, 2014). With the increasingly liberal cannabis 
policies globally likely to increase the number of new users (Hall and Weier, 2015), it 
is even more pertinent to verify how different aspects of cannabis use, including 
regular use, early initiation of use, and dependence may be associated with structural 
brain alterations.  
 
The psychoactive component of cannabis, delta9-tetrahydrocannabinol (THC), exerts 
its effect through cannabinoid receptors (CB1R) that are widely distributed in the 
human brain, particularly across the cortical surface (Gaoni and Mechoulam, 1964; 
Westlake et al., 1994). The cortical surface undergoes extensive developmental 
changes (e.g., in thickness, volume, and gyrification) across adolescence (Cao et al., 
2017; Coupé et al., 2017; Jacobus and Tapert, 2014; Toga et al., 2006). Importantly, 
such neurodevelopmental changes are in part driven by CB1Rs, as part of an 
endogenous cannabinoid system (ECS) involved in fundamental processes such as 
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neuronal cell proliferation, differentiation, morphogenesis and synaptogenesis 
(Harkany et al., 2008; Svíženská et al., 2008). Notably, THC exposure, especially 
during adolescence relative to adulthood, has been shown to demonstrably alter CB1R 
expression and neuronal growth in rats, potentially contributing to neurostructural 
alterations across the cortical surface (Burston et al., 2010; Dalton and Zavitsanou, 
2010; Dean et al., 2001; Grigorenko et al., 2002; Molina-Holgado et al., 2002; Rubino 
et al., 2015; Villares, 2007). Furthermore, rodent research shows that CB1R density 
increases during normal development, peaking in adolescence, before decreasing to 
adult values (de Fonseca et al., 1993). Thus, the evidence not only points toward a 
dynamic ECS heavily involved in modulating neuromaturational events during 
adolescence, but also implies a potential for the ECS to be more sensitive to 
cannabinoid insult during adolescence, that may contribute to observable 
neurostructural alterations along the cortical surface.  
  
Previous human neuroimaging studies have demonstrated differences in cortical 
thickness in cannabis users relative to non-using controls. However, these studies 
have not been consistent in the direction of reported results, nor the affected brain 
regions. For example, one study found that cannabis users had a thinner cortex in the 
right fusiform gyrus relative to non-using controls (Mashhoon et al., 2015a), while 
another reported thicker cortices in cannabis users in a number of regions across the 
frontal, parietal, temporal, and occipital lobes (Jacobus et al., 2015). Yet another 
found no significant difference in cortical thickness between cannabis users and 
controls (Mata et al., 2010). Adolescent onset of cannabis use may also moderate 
cortical thickness differences between cannabis users and controls, with one study 
finding that cannabis dosage was positively associated with cortical thickness across 
the frontal and temporal lobes in early onset (<16 years of age) users, but negatively 
associated with cortical thickness in late onset users (Filbey et al., 2015). However, 
other studies have instead demonstrated thinner cortices in the frontal and inferior and 
middle temporal brain regions; and thicker cortices in lingual, parietal, and 
paracentral regions, of early adolescent cannabis users relative to non-users (Jacobus 
et al., 2014; Lopez-Larson et al., 2011), making it difficult to infer a consistent effect 
of adolescent onset of cannabis use on cortical morphology. Finally, emerging 
evidence suggests that cannabis-associated effects on subcortical neuroanatomy and 
cortico-subcortical connectivity may be more reflective of problematic cannabis use 
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(i.e. cannabis dependence) rather than recreational use (Chye et al., 2017b, 2017c; 
Filbey and Dunlop, 2014). These studies particularly implicated frontal and limbic 
areas, thought to be involved in aberrant reward and decision-making processes in 
dependence (Volkow et al., 2003). The effect of cannabis dependence versus non-
dependent use, however, has yet to be explored in relation to cortical thickness. In 
sum, the lack of consistency of study findings to date makes it difficult to infer 
specific cortical morphological changes that may be associated with cannabis use, 
onset age, or dependence. 
 
In addition to cortical thickness, the surface morphology of the brain can also be 
examined via surface area and gyrification, both of which have been found to change 
with age, particularly during childhood and adolescence (Raznahan et al., 2011). The 
gyrification index is a quantitative approach to measuring the degree of cortical 
folding (Zilles et al., 1988). Only three studies, to our knowledge, have examined 
surface area and gyrification in relation to cannabis use, finding reduced gyrification 
and trend level reduction in surface area in frontal brain regions (Filbey et al., 2015; 
Mata et al., 2010; Shollenbarger et al., 2015). In this study we explored the cortical 
surface morphology – i.e. cortical thickness, surface area and gyrification index, in a 
multisite sample of regular cannabis users and controls aggregated from pre-collected 
data across four independent research sites (Batalla et al., 2013; Cousijn et al., 2014; 
Solowij et al., 2013; Yücel et al., 2016). We attempted to delineate the relation 
between cortical morphology, and (i) cannabis use, (ii) cannabis dependence, and (iii) 
cannabis onset age. While we are not able to formulate a directional hypothesis given 
the inconsistencies in the literature to date, we expect indices of surface morphology 
to be altered in cannabis users relative to controls, and that these differences will be 
more pronounced in dependent, as well as early-onset cannabis users.  
 
2. Experimental Procedures 
 
2.1. Participants 
Data from 140 cannabis users (CB) and 121 non-using controls (CON) were compiled 
from four independent imaging sites in Amsterdam (N = 76) (Cousijn et al., 2014), 
Barcelona (N = 55) (Batalla et al., 2013), Wollongong (N = 30) (Solowij et al., 2013), 
and Melbourne (N = 100) (Yücel et al., 2016). All CB had used cannabis at least two 
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days per month for at least two months, with most CB having almost daily use for a 
considerable time period (duration of regular use, Mdn = 6 years, range = 0.5 – 38 
years). Meanwhile, CON had used cannabis less than 50 times and did not use in the 
past month. Further inclusion and exclusion criteria have been reported previously 
(Chye et al., 2017a, 2017b). 
 
Measures related to participants’ demographic and substance use characteristics (i.e. 
age, gender, IQ, monthly standard alcoholic drinks, monthly cigarettes use, and 
cannabis use measures) were separately collected and standardised across sites. 
Estimated IQ was measured with the Dutch version of the National Adult Reading 
Test (DART; Schmand et al., 1991) in Amsterdam, the vocabulary subscale of the 
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) in 
Barcelona,  the National Adult Reading Test (NART; Nelson, 1982) in Wollongong, 
and the Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) in 
Melbourne. Cannabis use measures included monthly and lifetime cannabis 
consumption (measured in cones, https://cannabissupport.com.au/media/1593/ 
timeline-followback.pdf), age of initiation of regular cannabis use, and cannabis 
dependence. 
 
Information on cannabis dependence was collected from three of the four imaging 
sites – the Mini International Neuropsychiatric Interview’s (MINI) ‘non-alcohol 
psychoactive substance use disorders’ module, with a cut-off of 3 and above 
indicating dependence, in Amsterdam (Lecrubier et al., 1997); and the Severity of 
Dependence Scale (SDS), with a cut-off of 4 and above as dependent, in Barcelona 
and Melbourne (Gossop et al., 1995). This was used to separate the aggregated 
sample into 70 dependent users (CB-dep), 50 non-dependent users (CB-nondep), and 
106 CON, after excluding subjects with missing dependence information.  
 
Within cannabis users, age of initiation of regular cannabis use was also used to 
separate early to mid- adolescent-onset (EA-CB, initiation of regular cannabis use at 
16 years or younger) and late adolescent-onset (LA-CB, initiation at 17 years or 
older) users, across all four sites. This resulted in 50 EA-CB, 86 LA-CB, and 121 
CON. 
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2.2. Structural Image Processing 
T1-weighted structural MR images were acquired from the individual sites (Batalla et 
al., 2013; Chye et al., 2017a, 2017b; Cousijn et al., 2014; Solowij et al., 2013; Yücel 
et al., 2016), with two sites (Amsterdam and Wollongong) using a Phillips Intera 3T 
scanner with an 8-channel head coil, one site (Barcelona) using a GE Signa Excite 
1.5T scanner with an 8-channel head coil, and one site (Melbourne) using a Siemens-
Trio 3T scanner with a 32-channel head coil. 
 
All MR images underwent a noise removal step, using the prefiltered rotationally 
invariant nonlocal means filter (PRINLM) (https://sites.google.com/site/ 
pierrickcoupe/softwares/denoising-for-medical-imaging/mridenoising), to remove 
systematic variations due to noise (Fellhauer et al., 2015; Gaser and Coupé, 2010; 
Manjón et al., 2012). Subsequently, preprocessing for surface-based analysis was 
performed using FreeSurfer (http://surfer.nmr.mgh.harvard.edu/) version 5.3.0, which 
included motion correction (Reuter et al., 2010), non-uniform intensity normalisation 
(N3) at 500 iterations (Sled et al., 1998), automated Talairach transformation, removal 
of non-brain tissue (Ségonne et al., 2004), and tessellation of outer gray matter and 
white matter boundaries (Fischl et al., 2002). All reconstructions were visually 
inspected and manually edited as necessary by a blinded rater (Y.C.). The 
reconstructed surfaces were inflated and registered to a common spherical surface 
space, with a smoothing level – full width half maximum (FWHM) of 10mm, to allow 
for accurate matching of cortical locations across subjects (Fischl et al., 1999). 
 
Whole-brain vertex-wise measures of surface morphology – cortical thickness, 
surface area, and gyrification index were obtained. Cortical thickness reflects the 
distance between grey/white boundary and pial mesh at each vertex (Fischl and Dale, 
2000). The surface area is computed at the grey/white boundary, as the average area 
of all triangles surrounding each vertex. Finally, the 3D gyrification index represents 
the area ratio of the outer hull of the brain, and its actual convoluted pial surface 
(Schaer et al., 2012, 2008). 
 
 
Fig 1. Surface model of the brain, where vertex-wise (i) surface area represents the 
average area of all triangles surrounding each vertex on the grey/white matter surface; 
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(ii) cortical thickness represents the distance between the grey/white matter boundary 
and the pial surface; and (iii) gyrification index represents the area ratio between the 
smoothed outer surface of the brain and its convoluted pial surface 
 
2.3. Statistical Analysis 
Three sets of linear models were run, to test for the main effect of (i) cannabis use – 
CB vs. CON, (ii) cannabis dependence – CB-dep vs. CB-nondep vs. CON, and (iii) 
cannabis onset – EA-CB vs. LA-CB vs. CON respectively. All models were 
controlled for intracranial volume, imaging site, gender, age, IQ, alcohol use, and 
cigarette use.  
 
Statistical analysis was performed with a permutation-based approach through the 
Permutation Analysis of Linear Models (PALM; Winkler et al., 2014) tool. To 
accelerate permutation and inference, a tail-approximation approach with a lower 
number of permutation (i.e. 500) was adopted, as recommended by Winkler et al.  
(2016). Spatial statistics were computed using the threshold-free cluster enhancement 
(TFCE) method (height and extend parameters = 2 and 1 respectively; Smith and 
Nichols, 2009), which transforms vertex statistics by the vertex’s neighbouring 
cluster-like support. Inference was based on family-wise error rate (FWER)-corrected 




3.1. Cortical surface morphology by cannabis use 
Sample characteristics by cannabis use (i.e. CON and CB) are presented in Table 1. 
CB had a significantly lower IQ, and smoked significantly more cigarettes, than CON. 
When surface morphology was compared between CON and CB, controlling for age, 
gender, IQ, alcohol and nicotine use, imaging site, and intracranial volume, no 





 Cortical surface morphology in cannabis use 9 
Table 1 Sample characteristics of controls (CON) and cannabis users (CB) across 4 






Age (years) 26.12 (9.03) 28.03 (10.25) 1.58 
Gender (% M / F) 70.25 / 29.75 67.14 / 32.86 0.29 
IQa 109.31 (10.54) 103.45 (10.74)  -4.44*** 
Alcohol (StDr/mth)b 19.87 (23.77) 24.43 (25.18) 1.50 
Nicotine (Cig/mth)b 30.88 (97.92) 254.96 (233.77) 9.82*** 
Intracranial Volume, mm3 
(106) 
1.55 (0.20) 1.52 (0.17) -1.22 
Cannabis Use     
     Age of Regular Use  - 17.84 (3.38)  - 
     Current Use   
     (cones/month) 
- 334.08 (322.32) - 
     Lifetime Use (cones) - 57,107 (99,987) - 
a Estimated IQ measured with the Dutch version of the National Adult Reading Test 
(DART; Schmand et al., 1991) (Amsterdam), the vocabulary subscale of the Wechsler 
Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) (Barcelona);  
the National Adult Reading Test (NART; Nelson, 1982) (Wollongong); and the 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) (Melbourne).  
b StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month 
***p < .001 
 
3.2. Cortical surface morphology by cannabis dependence 
Sample characteristics by cannabis dependence (i.e. CON, CB-nondep, CB-dep) are 
presented in Table 2. CB-dep consumed significantly more cannabis per month 
relative to CB-nondep, but had comparable cannabis onset age and lifetime use. 
Similarly, we did not find any significant difference in cortical thickness, surface area, 
and gyrification index between CON, CB-nondep, or CB-dep. 
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Table 2 Sample characteristics of controls (CON), non-dependent (CB-nondep) and 
dependent (CB-dep) cannabis users across 3 sites (mean (SD)) 
 CON 






Age (years) 24.77 (7.91) 27.07 (10.33) 26.74 (9.18) 1.61 
Gender (% M / F) 66.98 / 33.02 60.00 / 40.00 64.29 / 35.71 0.73 
IQa 108.65 (10.71) 103.03 (11.13) 102.13 (10.86)  9.15***c 
Alcohol (StDr/mth)b 18.70 (23.90) 21.54 (25.03) 21.88 (22.78) 0.46 







1.53 (0.19) 1.46 (0.19) 1.53 (0.15) 2.72 
Cannabis Use      
   Age of Regular Use - 17.79 (2.66) 17.44 (3.23)  0.61 
   Current Use 






   Lifetime Use  






a Estimated IQ measured with the Dutch version of the National Adult Reading Test 
(DART; Schmand et al., 1991) (Amsterdam), the vocabulary subscale of the Wechsler 
Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) (Barcelona); 
and the Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) 
(Melbourne). 
b StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month 
c CON > CB-nondep, p = .003; CON > CB-dep, p <.001 
d CON < CB-nondep, p < .001; CON < CB-dep, p <.001 
*p<.05, ***p<.001 
 
3.3. Cortical surface morphology by onset of cannabis use 
Sample characteristics by onset of cannabis use (i.e. CON, EA-CB, LA-CB) are 
presented in Table 3. EA-CB smoked more cigarettes per month than did LA-CB, and 
also consumed more cannabis than LA-CB. However, no significant differences in 
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cortical thickness, surface area, and gyrification index were found between CON, EA-
CB, and LA-CB. 
 
Table 3 Sample characteristics of controls (CON), early to mid adolescent-onset (EA-
CB) and late adolescent-onset (LA-CB)a cannabis users across 4 sites (mean (SD)) 
 CON 






Age (years) 26.12 (9.03) 29.23 (10.06) 27.69 (10.47) 1.93 
Gender (% M / F) 70.25 / 29.75 60.00 / 40.00 69.77 / 30.23 1.88 
IQb 109.31 (10.54) 101.97 (11.65) 104.40 (10.25)  10.30***d 
Alcohol (StDr/mth)c 19.87 (23.77) 27.16 (28.74) 23.17 (23.29) 1.61 







1.55 (0.20) 1.55 (0.16) 1.50 (0.18) 1.72 
Cannabis Use      
   Age of Regular Use - 14.80 (1.25) 19.62 (2.93)  122.12*** 
   Current Use 






   Lifetime Use  






a Early adolescent-onset cannabis use (EA-CB) is defined as regular use by 16 years 
or younger, while late adolescent-onset cannabis use is defined as regular use 
commencing at 17 years or older. 
b Estimated IQ measured with the Dutch version of the National Adult Reading Test 
(DART; Schmand et al., 1991) (Amsterdam), the vocabulary subscale of the Wechsler 
Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) (Barcelona);  
the National Adult Reading Test (NART; Nelson, 1982) (Wollongong); and the 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) (Melbourne). 
c StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month 
d CON > EA-CB, p < .001; CON > LA-CB, p = .001 
e CON < EA-CB, p < .001; CON < LA-CB, p <.001; EA-CB > LA-CB, p = .003 
*p<.05, **p<.01, ***p<.001 
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4. Discussion 
 
While regular cannabis use has been associated with altered cortical morphology, 
previous findings have not been consistent in terms of the direction or region of 
alteration, which included increase, decrease, and lack of change in cortical 
morphology, across all four cortical lobes (Filbey et al., 2015; Jacobus et al., 2015, 
2014; Lopez-Larson et al., 2011; Mashhoon et al., 2015b; Shollenbarger et al., 2015). 
Furthermore, no study on cannabis use has yet comprehensively explored the three 
different indices of cortical surface morphology in tandem, with most studies 
examining cortical thickness, and only three to date further exploring surface area or 
gyrification (Filbey et al., 2015; Mata et al., 2010; Shollenbarger et al., 2015).  Here, 
we comprehensively examined cortical thickness, surface area, and gyrification index 
in relation to cannabis use, dependence, and onset age, across the whole cortex, and 
demonstrated no significant effects on cortical surface morphology.  
 
While our findings are inconsistent with some previous findings of altered cortical 
thickness in cannabis users relative to non-users, and furthermore did not support our 
hypotheses, they nevertheless reflect the lack of consistency in the evidence to date. 
Studies have alternately suggested cannabis use to be associated with thinner cortex in 
regions of the temporal and occipital lobe (Mashhoon et al., 2015a) and in the frontal 
lobe (Lopez-Larson et al., 2011), thicker cortex in the temporal and parietal lobe 
(Lopez-Larson et al., 2011), or thicker cortex in a number of regions across all frontal, 
parietal, temporal, and occipital lobe (Jacobus et al., 2015). Meanwhile, one further 
study also found no group difference in cortical thickness in cannabis users (Mata et 
al., 2010). While such discrepancy in findings may be due to other moderators such as 
onset age of regular cannabis use, as evidenced by the opposing association between 
cannabis dosage and cortical thickness found by one study in early vs. late onset users 
(Filbey et al., 2015), we did not find any effect of cortical morphology between early 
and late cannabis users. Our study has the benefit of being a large multisite study with 
a sample size of up to N=261 (in comparison to previous studies, N = 30 – 74), 
affording us greater statistical power to examine and verify previous findings.  
 
We additionally found no association between cortical surface area and gyrification 
index in relation to cannabis use. Although a number of studies have demonstrated 
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altered cortical volume (which reflects the product of surface area and cortical 
thickness) in relation to both cannabis use and cannabis dependence, particularly in 
the orbitofrontal cortex (Chye et al., 2017b; Filbey and Dunlop, 2014; Price et al., 
2015), it is unclear which component is driving these alterations. Only two previous 
studies have examined surface area in relation to cannabis use, and have similarly 
found no effect (Mata et al., 2010; Shollenbarger et al., 2015). However, these 
studies, when comparing cortical gyrification in adolescent and young adult cannabis 
users versus controls, showed bilaterally decreased sulci concavity in the frontal, 
temporal, and parietal lobes and thinner sulci in the right frontal lobe of users, 
contrary to our finding (Mata et al., 2010; Shollenbarger et al., 2015). A further study 
that compared gyrification in early onset (mean age of regular use 16.5 years) versus 
late onset (mean age of regular use 19 years) cannabis users further suggested that the 
association between cannabis use (quantity and duration) and reduced gyrification (in 
the PFC) is only apparent in early onset users (Filbey et al., 2015).  
 
Our lack of findings may be due to differences in analytic approach. A number of 
previous studies (i.e. those that have found thicker cortices, and those that have found 
lower gyrification, in cannabis users relative to non-users) explored region-of-interest 
(ROI)-level (Jacobus et al., 2015, 2014; Mata et al., 2010; Shollenbarger et al., 2015) 
rather than whole-brain vertex-level differences. While an ROI-level approach is 
useful in identifying less extreme group-averaged differences across larger pre-
defined regions, the latter is useful for identifying focal differences at a higher spatial 
resolution and across regional boundaries (Boulos et al., 2016; Li et al., 2014). 
Additionally, we adopted a permutation approach to analysing the data, an approach 
that is increasingly recommended as a non-parametric statistical alternative that is 
robust to non-random sampling (e.g. often in case-control studies), and has been 
demonstrated to have comparable power to parametric approaches (Ludbrook and 
Dudley, 1998; Winkler et al., 2016, 2014). Finally, we controlled for intracranial 
volume as a covariate in our cortical thickness analysis, despite cortical thickness 
scaling minimally with brain size (Im et al., 2008), compromising statistical power in 
favour of consistency across analysis of all surface morphometry. A limitation to our 
study however, is the cross-sectional design, which prevents us from verifying trends 
in surface morphology across neurodevelopment in cannabis users. Additionally, the 
restricted age range of our sample (range = 18 – 56) meant that we are not able to 
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fully explore age-related differences in relation to cannabis use (Klein et al., 2014; 
Lopez-Larson et al., 2011). 
 
Overall, this study examined cortical surface alteration related to cannabis use and 
onset, in a large multinational imaging cohort. We did not find any evidence of 
cortical surface alteration (i.e. cortical thickness, surface area, gyrification index) in 
relation to cannabis use, dependence, or age of initiation, despite previous evidence to 
the contrary. Our lack of finding in a well-powered study suggests that cortical 
surface morphology may be less associated with cannabis use than previously 
assumed. Nevertheless, we do not exclude potential underlying changes at the 
network or molecular level. The lack of consensus between past study findings, as 
well as our current finding, inadvertently echoes the opposing sentiments surrounding 
the harms and safety of long-term cannabis use. Given the current trend of widespread 
changes in cannabis regulation, it is even more prudent to carefully reassess the 
evidence surrounding cannabis-related effects, to guide informed policy and decision-
making.  
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